NCT00286039

Brief Summary

Correlation between determination of citrulline in plasma or dried blood Reference ranges for healthy children and babies Longitudinal follow-up of citrulline in preterm babies

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2005

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 1, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 2, 2006

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
Last Updated

July 13, 2021

Status Verified

July 1, 2021

Enrollment Period

5.1 years

First QC Date

February 1, 2006

Last Update Submit

July 7, 2021

Conditions

Intestinal Failure

Outcome Measures

Primary Outcomes (3)

  • Correlation between determination of citrulline in plasma or dried blood

    Untill end of study

  • Reference ranges for healthy children and babies

    Until end of study

  • Longitudinal follow-up of citrulline in preterm babies

    Untill end of study

Interventions

Blood samplingPROCEDURE

Blood sampling is used.

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years
  • preterm babies up to 1.500g
  • preterm babies over 1.500g

You may not qualify if:

  • gastro-intestinal problems (except for the preterm babies)
  • congenital metabolic disorders
  • dysfunction of the liver or kidneys
  • congenital defects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Links

MeSH Terms

Conditions

Intestinal Failure

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Eddy Robberecht, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2006

First Posted

February 2, 2006

Study Start

August 1, 2005

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

July 13, 2021

Record last verified: 2021-07

Locations

BE(1)